Page last updated: 2024-10-30

memantine and Pyrexia

memantine has been researched along with Pyrexia in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Three phase 2 trials were conducted to assess the efficacy and long-term safety of weight-based memantine extended release (ER) treatment in children with autism spectrum disorder."9.30Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies. ( Ali, S; Aman, MG; Andersen, KA; Graham, SM; Hardan, AY; Hendren, RL; Jia, XD; Lateiner, JE; Luchini, R; Mallick, M; Melmed, RD; Palmer, RH; Rahman, R; Robb, A, 2019)
"Pretreatment with risperidone (0."5.32Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome. ( Kato, S; Nisijima, K; Shioda, K; Takano, K; Yoshino, T, 2004)
"Three phase 2 trials were conducted to assess the efficacy and long-term safety of weight-based memantine extended release (ER) treatment in children with autism spectrum disorder."5.30Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies. ( Ali, S; Aman, MG; Andersen, KA; Graham, SM; Hardan, AY; Hendren, RL; Jia, XD; Lateiner, JE; Luchini, R; Mallick, M; Melmed, RD; Palmer, RH; Rahman, R; Robb, A, 2019)
"Pretreatment with risperidone (0."1.32Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome. ( Kato, S; Nisijima, K; Shioda, K; Takano, K; Yoshino, T, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hardan, AY1
Hendren, RL1
Aman, MG1
Robb, A1
Melmed, RD1
Andersen, KA1
Luchini, R1
Rahman, R1
Ali, S1
Jia, XD1
Mallick, M1
Lateiner, JE1
Palmer, RH1
Graham, SM1
Nisijima, K2
Kuboshima, K1
Shioda, K2
Yoshino, T2
Iwamura, T1
Kato, S2
Takano, K1

Trials

1 trial available for memantine and Pyrexia

ArticleYear
Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies.
    Autism : the international journal of research and practice, 2019, Volume: 23, Issue:8

    Topics: Autism Spectrum Disorder; Child; Delayed-Action Preparations; Double-Blind Method; Early Termination

2019

Other Studies

2 other studies available for memantine and Pyrexia

ArticleYear
Memantine attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in rats.
    Neuroscience letters, 2012, Dec-07, Volume: 531, Issue:2

    Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Fever; Ha

2012
Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome.
    Pharmacopsychiatry, 2004, Volume: 37, Issue:2

    Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Clorgyline; Disease Models, Animal; Dizocilpine Male

2004